Zombie Unicorn

A zombie unicorn is a company that achieved a $1B+ primary-round valuation but has since stagnated: growth has slowed or reversed, fundraising has dried up, and the secondary market — if it's liquid at all — implies a valuation far below $1B. The company is not dead (it has some revenue and operational continuity) but it has no credible path to a value-creating liquidity event.

Zombie unicorns typically emerged from the 2020–2021 funding boom, when companies raised at peak valuations justified by high-multiple public market comps. When public market multiples compressed in 2022, those private valuations became mathematically indefensible. Without a forced recapitalization or down round, many companies avoided official write-downs and continued operating, slowly consuming their cash reserves.

Illustrative example: a company raised at a $3B valuation in 2021. Revenue is flat; net burn is $5M/month. The company has 18 months of runway. Secondary transactions, when they occur, imply a $600–800M valuation. No new investors will price a round above $1B given the current metrics. The company is a zombie unicorn: alive, labeled a unicorn, but functionally worth less and unable to attract capital at that label.

The edge the pros know: zombie unicorns can be value traps in secondary markets. Sellers may be motivated precisely because they can see the trajectory clearly. Secondary buyers attracted to the unicorn label at a "discounted" price may still be overpaying for a company with no realistic exit. Apply realistic exit scenario modeling — not just valuation-vs-mark analysis — before purchasing shares.